Protein Deimination in Human Health and Disease

Published in 2014,  Protein Deimination in Human Health and Disease  was the first book on this novel post-translational modification, in which selected positively-charged arginine amino acids are converted to neutral citrulline amino acids by the peptidyl-arginine deiminase (PAD) family of enzymes....

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Nicholas, Anthony P. (Επιμελητής έκδοσης), Bhattacharya, Sanjoy K. (Επιμελητής έκδοσης), Thompson, Paul R. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2017.
Έκδοση:2nd ed. 2017.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03579nam a22004815i 4500
001 978-3-319-58244-3
003 DE-He213
005 20170920150504.0
007 cr nn 008mamaa
008 170920s2017 gw | s |||| 0|eng d
020 |a 9783319582443  |9 978-3-319-58244-3 
024 7 |a 10.1007/978-3-319-58244-3  |2 doi 
040 |d GrThAP 
050 4 |a RC321-580 
072 7 |a PSAN  |2 bicssc 
072 7 |a MED057000  |2 bisacsh 
082 0 4 |a 612.8  |2 23 
245 1 0 |a Protein Deimination in Human Health and Disease  |h [electronic resource] /  |c edited by Anthony P. Nicholas, Sanjoy K. Bhattacharya, Paul R. Thompson. 
250 |a 2nd ed. 2017. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2017. 
300 |a IX, 474 p. 116 illus., 81 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
520 |a Published in 2014,  Protein Deimination in Human Health and Disease  was the first book on this novel post-translational modification, in which selected positively-charged arginine amino acids are converted to neutral citrulline amino acids by the peptidyl-arginine deiminase (PAD) family of enzymes. This area of research continues to expand rapidly, necessitating the need for this second edition. Chronicling the latest inflammatory, epigenetic, neurodegenerative, and carcinogenic processes,  Protein Deimination in Human Health and Disease, Second Edition, updates the latest advances in deimination research, including new information on PAD enzyme structure and activity, and how PAD knock-out animals are being used to study known and newly-discovered links to various human diseases. The first edition outlined what was known about citrullinated proteins in normal tissues such as skin and hair, as well as in maladies such as rheumatoid arthritis (RA), multiple sclerosis (MS), Alzheimer’s disease (AD), glaucoma, peripheral nerve injury, neonatal hypoxic brain damage, and breast cancer. This second edition addresses numerous additional disorders such as diabetes, asthma, traumatic brain injury, inflammatory bowel disease, lupus, bone disease, heart failure, fronto-temporal dementia, and prostate and colon cancer. It also provides updates on the deimination research covering the three seminal diseases first linked to this process (RA, MS and AD), and details how auto-antibodies against citrullinated proteins contribute to disease. In addition, new hypotheses on the possible pathologic mechanisms of citrullinated myelin basic protein and glial fibrillary acidic protein are also proposed. This second edition also outlines the latest developments in therapeutic strategies, including the use of new PAD antagonists and innovative techniques such as micro-vescicles and stem cells as possible mechanisms to treat these conditions. 
650 0 |a Medicine. 
650 0 |a Immunology. 
650 0 |a Neurosciences. 
650 0 |a Proteins. 
650 1 4 |a Biomedicine. 
650 2 4 |a Neurosciences. 
650 2 4 |a Immunology. 
650 2 4 |a Protein Science. 
700 1 |a Nicholas, Anthony P.  |e editor. 
700 1 |a Bhattacharya, Sanjoy K.  |e editor. 
700 1 |a Thompson, Paul R.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319582436 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-58244-3  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)